Home > Balance Sheet > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
Total Current Liabilities

    Back to Balance Sheet
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

EMCURE PHARMACEUTICALS Last 5 Year Total Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Current Liabilities ₹2,668 Cr₹3,210 Cr₹3,019 Cr₹2,965 Cr₹3,408 Cr

What is the latest Total Current Liabilities ratio of EMCURE PHARMACEUTICALS ?

The latest Total Current Liabilities ratio of EMCURE PHARMACEUTICALS is ₹2,668 Cr based on Mar2025 Consolidated results.
Year Total Current Liabilities
Mar2025₹2,668 Cr
Mar2024₹3,210 Cr
Mar2023₹3,019 Cr
Mar2022₹2,965 Cr
Mar2021₹3,408 Cr

How is Total Current Liabilities of EMCURE PHARMACEUTICALS Trending?

Years Total Current Liabilities % Change
Mar2025 ₹2,668 Cr
-16.89
Mar2024 ₹3,210 Cr
6.34
Mar2023 ₹3,019 Cr
1.83
Mar2022 ₹2,965 Cr
-13.01
Mar2021 ₹3,408 Cr -

Compare Total Current Liabilities of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹30,350.2 Cr 3.5% 13.2% 48.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹397,018.0 Cr 1.3% -4.5% -0% Stock Analytics
DIVIS LABORATORIES ₹162,454.0 Cr 1.7% -5.9% 3.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹140,702.0 Cr 2.6% -5% 25.5% Stock Analytics
DR REDDYS LABORATORIES ₹102,830.0 Cr -0.4% -7% 3.6% Stock Analytics
CIPLA ₹99,325.0 Cr 2.6% -7.4% -16.3% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

3.5%

13.2%

48.3%

SENSEX

5.8%

-1.7%

1.2%


You may also like the below Video Courses